Tag : Antibiotic

Latest News

Qurient Announces Publication in New England Journal of Medicine of Phase 2 Data for Telacebec, a First-in-Class Antibiotic for the Treatment of Tuberculosis

Newsemia
SEONGNAM-SI, Korea–(BUSINESS WIRE)– #Antibiotic–Qurient announced the publication in NEJM of positive results from the Phase 2 clinical trial for telacebec for the treatment of tuberculosis...
Biology

Differential DNA accessibility to polymerase enables 30-minute phenotypic β-lactam antibiotic susceptibility testing of carbapenem-resistant Enterobacteriaceae

Newsemia
by Nathan G. Schoepp, Eric J. Liaw, Alexander Winnett, Emily S. Savela, Omai B. Garner, Rustem F. Ismagilov The rise in carbapenem-resistant Enterobacteriaceae (CRE) infections...
Biology

Surfactant-enhanced DNA accessibility to nuclease accelerates phenotypic β-lactam antibiotic susceptibility testing of <i>Neisseria gonorrhoeae</i>

Newsemia
by Emily S. Savela, Nathan G. Schoepp, Matthew M. Cooper, Justin C. Rolando, Jeffrey D. Klausner, Olusegun O. Soge, Rustem F. Ismagilov Rapid antibiotic susceptibility...
AI/ML

Analysis of Identification Method for Bacterial Species and Antibiotic Resistance Genes Using Optical Data From DNA Oligomers.

Newsemia
Related Articles Analysis of Identification Method for Bacterial Species and Antibiotic Resistance Genes Using Optical Data From DNA Oligomers. Front Microbiol. 2020;11:257 Authors: Wood RL,...
Latest News

Best practices for infection control can protect healthcare workers during COVID-19 outbreak

Newsemia
Health systems can protect healthcare workers during the COVID-19 outbreak when best practices for infection control are diligently applied along with lessons learned from recent...
Latest News

Artificial Intelligence brings a novel antibiotic compound

Newsemia
Researchers from the Massachusetts Institute of Technology (MIT) have made a scientific breakthrough where their machine-learning algorithm or Artificial Intelligence (AI) program successfully created a...

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy